Seelos therapeutics announces year end 2020 business update

New york, jan. 6, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced its year end 2020 business update. "this past year...
SEEL Ratings Summary
SEEL Quant Ranking